Multivariate analysis of countries’ government and health-care system influences on opioid availability for cancer pain relief and palliative care: More than a function of human development

Abstract

Background:

Many international governmental and nongovernmental organizations regard unrelieved cancer pain as a significant global public health problem. Although opioids such as morphine are considered essential medicines in the provision of palliative care and for treating cancer pain, especially when the pain is severe, low- and middle-income countries often lack such medications.

Aim:

The primary aim of this study was to examine countries’ government and health-care system influences on opioid availability for cancer pain and palliative care, as a means to identify implications for improving appropriate access to prescription opioids.

Design:

A multivariate regression of 177 countries’ consumption of opioids (in milligrams/death from cancer and AIDS) contained country-level predictor variables related to public health, including Human Development Index, palliative care infrastructure, and health system resources and expenditures.

Results:

Results were highly explanatory (adjusted R² = 82%) and Human Development Index was the most predictive variable when controlling for all other factors in the statistical model (B = 11.875, confidence interval = 10.216, 13.534, p < 0.0001).

Conclusions:

Study findings demonstrate that a limited number of predictor variables characterizing a country’s government and health-care system infrastructure can explain its opioid consumption level, with the greatest influence being very high Human Development Index. However, Human Development Index is not the most policy-relevant factor, and this finding should be reconciled against the reality that many countries with low or medium Human Development Index have succeeded in creating and sustaining a health-care system to strengthen cancer pain care and palliative care, including through the appropriate use of essential prescription opioids.

Keywords

Cancer pain opioid analgesics palliative care

Get full access to this article

View all access options for this article.

References

Jemal

Bray

Center

. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69–90.

World Health Organization. World cancer report 2008. Lyon: IARC Press, 2008.

World Bank. How we classify countries, http://data.worldbank.org/about/country-classifications (accessed 12 September 2011).

Seya

Gelders

SFAM

Achara

. A first comparison between the consumption of and the need for opioid analgesics at country, regional and global level. J Pain Palliat Care Pharmacother 2011; 25(1): 6–18.

World Health Organization. Cancer pain relief: with a guide to opioid availability. 2nd ed. Geneva: World Health Organization, 1996.

Caraceni

Hanks

Kaasa

. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: e58–e68.

Woodruff

Cameron

. HIV/AIDS in adults. In: Hanks

Cherny

Christakis

. (eds) Oxford textbook of palliative medicine. 4th ed. New York: Oxford University Press, 2010, pp. 1195–1230.

Fallon

Cherny

Hanks

. Opioid analgesic therapy. In: Hanks

Cherny

Christakis

. (eds) Oxford textbook of palliative medicine. 4th ed. New York: Oxford University Press, 2010, pp. 661–698.

World Health Organization. WHO Guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Geneva: World Health Organization, 2012.

10.

World Health Organization. WHO Model List of Essential Medicines, 17th List http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf. http://apps.who.int/emlib/MedicineDisplay.aspx?Language=EN&;MedIDName=217%40morphine 2011, (accessed 12 September 2011).

11.

Milani

Scholten

. Access to controlled medicines. In: World Health Organization (ed.) The world medicines situation 2011. 3rd ed. Geneva: World Health Organization, 2011, pp. 1–20.

12.

United Nations Economic and Social Council. Promoting adequate availability of internationally controlled narcotic drugs and psychotropic substances for medical and scientific purposes while preventing their diversion and abuse. Resolution 54/6. Vienna: United Nations, 2011.

13.

United Nations Economic and Social Council. Treatment of pain using opioid analgesics. Resolution 2005–25. Vienna: United Nations, 2005.

14.

World Health Assembly. Cancer prevention and control. Resolution WHA 58.22. Geneva: World Health Organization, 2005.

15.

World Health Organization. Ensuring balance in national policies on controlled substances: guidance for availability and accessibility of controlled medicines. 2nd and Revised ed. Geneva: World Health Organization, 2011.

16.

International Narcotics Control Board. Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes. New York: United Nations, 2011.

17.

United Nations. Single convention on narcotic drugs, 1961 (as amended by the 1972 protocol amending the single convention on narcotic drugs, 1961). Geneva: United Nations, 1972.

18.

Joranson

Ryan

Maurer

. Opioid policy, availability and access in developing and nonindustrialized countries. In: Fishman

Ballantyne

Rathmell

(eds) Bonica’s management of pain. 4th ed. Baltimore, MD: Lippincott Williams & Wilkins, 2010, pp. 194–208.

19.

Foley

. How well is cancer pain treated? Palliat Med 2011; 25(5): 398–401.

20.

International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2010-statistics for 2008. New York: United Nations, 2010.

21.

Gilson

Maurer

Ryan

. Using a morphine equivalence metric to quantify opioid consumption: examining the capacity to provide effective treatment of debilitating pain at the global, regional and country levels. J Pain Symptom Manage . doi:10.1016/j.jpainsymman.2012.03.011.

22.

International Narcotics Control Board. Report of the International Narcotics Control Board on follow-up to the twentieth special session of the general assembly, 2008. New York: United Nations, 2009.

23.

Adams

. Access to pain relief—an essential human right: a report for world hospice and palliative care day 2007. Report. London: Help the Hospices for the Worldwide Palliative Care Alliance, 2007.

24.

Human Rights Watch. Global state of pain treatment: access to palliative care as a human right. Report. New York: Human Rights Watch, 2011.

25.

García del Pozo

Carvajal

Rueda De Castro

. Opioid consumption in Spain—the significance of a regulatory measure. Eur J Clin Pharmacol 1999; 55: 681–683.

26.

García del Pozo

Carvajal

Viloria

. Trends in the consumption of opioid analgesics in Spain: higher increases as fentanyl replaces morphine. Eur J Clin Pharmacol 2008; 64: 411–415.

27.

Wright

Wood

Lynch

. Mapping levels of palliative care development: a global view. J Pain Symptom Manage 2008; 35(5): 469–485.

28.

Cherny

Baselga

De Conno

. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Ann Oncol 2010; 21(3): 615–626.

29.

Ponizovsky

Marom

Zeldin

. Trends in opioid analgesics consumption, Israel, 2000-2008. Eur J Clin Pharmacol 2011; 67(2): 165–168.

30.

Hamunen

Paakkari

Kalso

. Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 2009; 13: 954–962.

31.

Harding

Powell

Kiyange

. Provision of pain- and symptom-relieving drugs for HIV/AIDS in sub-Saharan Africa. J Pain Symptom Manage 2010; 40(3): 405–415.

32.

Zenz

Tryba

. Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage 1995; 10(3): 187–191.

33.

Jarlbaek

Andersen

Hallas

. Use of opioids in a Danish population-based cohort of cancer patients. J Pain Symptom Manage 2005; 29(4): 336–343.

34.

De Conno

Ripamonti

Brunelli

. Opioid purchases and expenditure in nine western European countries: ‘Are we killing off morphine?’. Palliat Med 2005; 19(3): 179–184.

35.

De Lima

Sweeney

Palmer

. Potent analgesics are more expensive for patients in developing countries: a comparative study. J Pain Palliat Care Pharmacother 2004; 18(1): 59–70.

36.

United Nations Development Programme. Human development report 2009, overcoming barriers: human mobility and development. New York: Palgrave Macmillan, 2009.

37.

World Health Organization. Global burden of disease death estimates for 2008 by cause and sex. Geneva: World Health Organization, 2011.

38.

World Health Organization. World health statistics 2010. Geneva: World Health Organization, 2010.

39.

Tabachnick

Fidell

. Using multivariate statistics. 5th ed. Boston, MA: Pearson, 2007.

40.

Azmera

. Palliative care & pain relief. Addis Ababa, Ethiopia: Pain & Palliative Care Society, 2011.

41.

Stjernswärd

Ferris

Khleif

. Jordan palliative care initiative: a WHO demonstration project. J Pain Symptom Manage 2007; 33(5): 628–633.

42.

Bosnjak

Maurer

Ryan

. Improving the availability and accessibility of opioids for the treatment of pain: the International Pain Policy Fellowship. Support Care Cancer 2011; 19(8): 1239–1247.

43.

Krakauer

Cham

Khue

. Vietnam’s palliative care initiative: successes and challenges in the first five years. J Pain Symptom Manage 2010; 40(1): 27–30.

44.

Republic of Kenya Ministry of Public Health and Sanitation and Ministry of Medical Services. National cancer control strategy, 2011–2016. Nairobi, Kenya: Republic of Kenya Ministry of Public Health and Sanitation and Ministry of Medical Services, 2011.

45.

Joranson

Rajagopal

Gilson

. Improving access to opioid analgesics for palliative care in India. J Pain Symptom Manage 2002; 24(2): 152–159.

46.

Jamaica Ministry of Health. Policy for patient access, and safe management of controlled drugs. Kingston, ON, Canada: Jamaica Ministry of Health, 2010.

47.

Davaasuren

Stjernswärd

Callaway

. Mongolia: establishing a national palliative care program. J Pain Symptom Manage 2007; 33(5): 568–572.

48.

Jack

Merriman

. Dying without pain: nurses giving morphine in Uganda. Eur J Palliat Care 2008; 15(2): 92–95.